MedPath

Treatment of Iatrogenic Subcutaneous Abdominal Wounds (ISAW) after surgery

Not Applicable
Completed
Conditions
Iatrogenic Subcutaneous Abdominal Wounds
Injury, Occupational Diseases, Poisoning
Registration Number
ISRCTN44577192
Lead Sponsor
niversity Witten/Herdecke (Germany)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
250
Inclusion Criteria

1. Acute subcutaneous abdominal wound-healing impairment after surgical intervention
2. Sizes of wound opening (maximum diameter = 3 cm)
3. Wound depth = 3 cm
4. Wound surface = 9 cm2

Exclusion Criteria

1. Lack of infrastructure for outpatient continuation of treatment and study-specific interventions
2. Existence of an open abdominal fascia
3. Acute serious organ failure
4. Application of an other active vacuum device at the wound treated during the study conduct within 8 days before screening visit
5. Ongoing/during 3 weeks after chemo therapy
6. Ongoing/during 3 weeks after radiation therapy
7. Contraindications in accordance with the safety precautions issued by the FDA or the companies

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. Time (number of days) to the achievement of complete wound closure (Time-to-Closure) within 42 days of treatment<br>2. Number of achieved wound closures within maximum therapy period (Rate-of-Closure) within 42 days of treatment
Secondary Outcome Measures
NameTimeMethod
1. Reduction of wound volume in the course of treatment (over time)<br>2. Wound infections<br>3. Relapses<br>4. Pain<br>5. Quality of Live<br>6. Patient-related endpoints / Patient Reported Outcome (PRO)<br>7. Consumption of resources in inpatient and outpatient setting and costs (economically orientated outcome parameters)<br>8. Stratification according to wound volume and study centre
© Copyright 2025. All Rights Reserved by MedPath